ADCK2 and breast neuroendocrine neoplasm: Between breast NETs and IDCs, only pathogenetic or unknown variant frequencies of TP53 (11.3% in breast NETs and 41% in IDCs, adjusted p value 0.027) and ADCK2 (9.4% in breast NETs vs. 0.28% in IDCs, adjusted p value 0.045) were significantly different (Supplementary Fig. 3).